Schrag A - Search Results

1

Developing and assessing a new web-based tapping test for measuring distal movement in Parkinson's disease: a Distal Finger Tapping test.

Akram N, Li H, Ben-Joseph A, Budu C, Gallagher DA, Bestwick JP, Schrag A, Noyce AJ, Simonet C. Akram N, et al. Among authors: schrag a. Sci Rep. 2022 Jan 10;12(1):386. doi: 10.1038/s41598-021-03563-7. Sci Rep. 2022. PMID: 35013372 Free PMC article.

2

Rate of clinical progression in Parkinson's disease. A prospective study.

Schrag A, Dodel R, Spottke A, Bornschein B, Siebert U, Quinn NP. Schrag A, et al. Mov Disord. 2007 May 15;22(7):938-45. doi: 10.1002/mds.21429. Mov Disord. 2007. PMID: 17415791

3

Pathological gambling in Parkinson's disease: risk factors and differences from dopamine dysregulation. An analysis of published case series.

Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Gallagher DA, et al. Among authors: schrag a. Mov Disord. 2007 Sep 15;22(12):1757-63. doi: 10.1002/mds.21611. Mov Disord. 2007. PMID: 17580327

4

Unified Parkinson's Disease Rating Scale (UPDRS) part I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.

Gallagher DA, Lees AJ, Schrag A. Gallagher DA, et al. Among authors: schrag a. Parkinsonism Relat Disord. 2008 Nov;14(7):586-7. doi: 10.1016/j.parkreldis.2008.01.005. Epub 2008 Mar 6. Parkinsonism Relat Disord. 2008. PMID: 18328769 No abstract available.

5

Impact of newer pharmacological treatments on quality of life in patients with Parkinson's disease.

Gallagher DA, Schrag A. Gallagher DA, et al. Among authors: schrag a. CNS Drugs. 2008;22(7):563-86. doi: 10.2165/00023210-200822070-00003. CNS Drugs. 2008. PMID: 18547126 Review.

6

Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease.

Lim SY, O'Sullivan SS, Kotschet K, Gallagher DA, Lacey C, Lawrence AD, Lees AJ, O'Sullivan DJ, Peppard RF, Rodrigues JP, Schrag A, Silberstein P, Tisch S, Evans AH. Lim SY, et al. Among authors: schrag a. J Clin Neurosci. 2009 Sep;16(9):1148-52. doi: 10.1016/j.jocn.2008.12.010. Epub 2009 Jun 23. J Clin Neurosci. 2009. PMID: 19553125

7

What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?

Gallagher DA, Lees AJ, Schrag A. Gallagher DA, et al. Among authors: schrag a. Mov Disord. 2010 Nov 15;25(15):2493-500. doi: 10.1002/mds.23394. Mov Disord. 2010. PMID: 20922807

8

Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.

Gallagher DA, Goetz CG, Stebbins G, Lees AJ, Schrag A. Gallagher DA, et al. Among authors: schrag a. Mov Disord. 2012 Jan;27(1):79-83. doi: 10.1002/mds.23939. Epub 2011 Sep 13. Mov Disord. 2012. PMID: 21915909

9

Testing an aetiological model of visual hallucinations in Parkinson's disease.

Gallagher DA, Parkkinen L, O'Sullivan SS, Spratt A, Shah A, Davey CC, Bremner FD, Revesz T, Williams DR, Lees AJ, Schrag A. Gallagher DA, et al. Among authors: schrag a. Brain. 2011 Nov;134(Pt 11):3299-309. doi: 10.1093/brain/awr225. Epub 2011 Sep 15. Brain. 2011. PMID: 21921019

10

Psychosis, apathy, depression and anxiety in Parkinson's disease.

Gallagher DA, Schrag A. Gallagher DA, et al. Among authors: schrag a. Neurobiol Dis. 2012 Jun;46(3):581-9. doi: 10.1016/j.nbd.2011.12.041. Epub 2012 Jan 3. Neurobiol Dis. 2012. PMID: 22245219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

347 results

Search Page